This is a preprint.
Genomic loss of GPR108 disrupts AAV transduction in birds
- PMID: 38798475
- PMCID: PMC11118497
- DOI: 10.1101/2024.05.16.589954
Genomic loss of GPR108 disrupts AAV transduction in birds
Abstract
The G protein-coupled receptor 108 (GPR108) gene encodes a protein factor identified as critical for adeno-associated virus (AAV) entry into mammalian cells, but whether it is universally involved in AAV transduction is unknown. Remarkably, we have discovered that GPR108 is absent in the genomes of birds and in most other sauropsids, providing a likely explanation for the overall lower AAV transduction efficacy of common AAV serotypes in birds compared to mammals. Importantly, transgenic expression of human GPR108 and manipulation of related glycan binding sites in the viral capsid significantly boost AAV transduction in zebra finch cells. These findings contribute to a more in depth understanding of the mechanisms and evolution of AAV transduction, with potential implications for the design of efficient tools for gene manipulation in experimental animal models, and a range of gene therapy applications in humans.
Conflict of interest statement
Competing interests HN receives royalties of AAV-related technologies licensed by Takara Bio Inc. and Capsigen Inc., serves as a consultant for biotech companies, and is a co-founder of Capsigen Inc., a company commercializing AAV vector-related technologies. SJH receives royalties from Capsigen Inc. All other authors declare no competing interests.
Figures


References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials